Icon close

Close

People

Matt Baughman has more than two decades of experience handling the most sensitive and high-profile government investigations of companies and executives in crisis situations.  A known and trusted adviser, Matt is individually ranked by Chambers and Partners in the White-Collar Crime & Government Investigations category, and he has also been recognized by SuperLawyers

Matt has deep experience working both as an attorney in the Enforcement Division of the Securities and Exchange Commission as well as, more recently, in a top position at the Department of Justice as Associate Deputy Attorney General in charge of white-collar enforcement.  In both government and private practice, he has handled corporate cases from the first document demand all the way through litigation.  Matt has a unique understanding of the government’s corporate enforcement policy, having spearheaded the development of policies at DOJ relating to corporate cooperation, individual accountability, fines and penalties in parallel investigations, corporate compliance, monitorships, and False Claims Act cases. 

Matt has particular experience in financial fraud, accounting, and auditing cases, having represented Big Four accounting firms in dozens of investigations.  Over the course of his career, he has represented companies and individuals in more than 50 matters with the SEC, some of which were jointly investigated by DOJ.  He has counseled companies, boards, and executives in high-profile investigations of cybersecurity issues, public disclosure and accounting, foreign bribery and domestic corruption, and insider trading. 

Matt also has deep expertise representing healthcare providers, pharmaceutical companies, and medical device manufacturers in numerous healthcare fraud investigations by DOJ and other federal and state enforcers.  He regularly counsels companies subject to parallel investigations, and his experience enables him to coordinate a client’s response to multiple investigatory, litigation, and public relations challenges that can culminate into an enterprise-threatening crisis. 

Matt is a Certified Compliance and Ethics Professional™.  He began his career as a litigator at the New York law firm Wachtell, Lipton, Rosen & Katz.  Matt held positions in government from 2003 to 2006, and again from 2018 to 2019. 

Full Bio

Credentials

J.D., Harvard University, magna cum laude

B.A., Furman University, summa cum laude

Georgia

New York

Law Clerk, Judge Gerald Bard Tjoflat, U.S. Court of Appeals for the Eleventh Circuit

Matters

Represented financial institution in cyber-intrusion case investigated by DOJ, SEC, FTC, and state enforcement authorities including Attorneys General.

Represented medical device manufacturer in Food, Drug, and Cosmetic Act investigation by DOJ, FDA, HHS-OIG, Veterans Affairs, and Department of Defense; litigated and obtained dismissal of qui tam actions. 

Represented global automotive manufacturer in high-profile congressional and regulatory investigations related to vehicle safety issues.

See more
Icon close

Close

Matters

Represented financial institution in cyber-intrusion case investigated by DOJ, SEC, FTC, and state enforcement authorities including Attorneys General.

Represented medical device manufacturer in Food, Drug, and Cosmetic Act investigation by DOJ, FDA, HHS-OIG, Veterans Affairs, and Department of Defense; litigated and obtained dismissal of qui tam actions. 

Represented global automotive manufacturer in high-profile congressional and regulatory investigations related to vehicle safety issues.

Represented national home health provider in parallel investigations by DOJ, eight U.S. Attorney’s Offices, HHS-OIG, Congress, and the SEC in case involving medical necessity, patient eligibility, and related financial statement disclosures.

Represented pharmaceutical manufacturer in global resolution of off-label investigation, involving DOJ, the U.S. Attorney’s Office, HHS-OIG, and all fifty states.

Represented Big Four audit firm in multiple SEC investigations of mortgage-backed securities issues.

Represented national health system in False Claims Act investigation of hospital short-stays.

Represented former Government official in national SEC investigation of alleged insider trading involving political intelligence firms and Government agencies.

Represented health care provider in largest non-intervened False Claims Act case in history.

Represented Fortune 500 financial institution in self-disclosure to the SEC, resulting in no charges against client.

Represented medical device manufacturer in publicized criminal and civil investigations by DOJ, multiple U.S. Attorney’s Offices, FDA, and VA-OIG of allegations of non-conforming products.

Represented Fortune 50 financial institution in global settlement of municipal securities issues.

Represented Big Four audit firm in SEC investigation involving failed Puerto Rican financial institution.

Matters

Represented financial institution in cyber-intrusion case investigated by DOJ, SEC, FTC, and state enforcement authorities including Attorneys General.

Represented medical device manufacturer in Food, Drug, and Cosmetic Act investigation by DOJ, FDA, HHS-OIG, Veterans Affairs, and Department of Defense; litigated and obtained dismissal of qui tam actions. 

Represented global automotive manufacturer in high-profile congressional and regulatory investigations related to vehicle safety issues.

See more
Icon close

Close

Matters

Represented financial institution in cyber-intrusion case investigated by DOJ, SEC, FTC, and state enforcement authorities including Attorneys General.

Represented medical device manufacturer in Food, Drug, and Cosmetic Act investigation by DOJ, FDA, HHS-OIG, Veterans Affairs, and Department of Defense; litigated and obtained dismissal of qui tam actions. 

Represented global automotive manufacturer in high-profile congressional and regulatory investigations related to vehicle safety issues.

Represented national home health provider in parallel investigations by DOJ, eight U.S. Attorney’s Offices, HHS-OIG, Congress, and the SEC in case involving medical necessity, patient eligibility, and related financial statement disclosures.

Represented pharmaceutical manufacturer in global resolution of off-label investigation, involving DOJ, the U.S. Attorney’s Office, HHS-OIG, and all fifty states.

Represented Big Four audit firm in multiple SEC investigations of mortgage-backed securities issues.

Represented national health system in False Claims Act investigation of hospital short-stays.

Represented former Government official in national SEC investigation of alleged insider trading involving political intelligence firms and Government agencies.

Represented health care provider in largest non-intervened False Claims Act case in history.

Represented Fortune 500 financial institution in self-disclosure to the SEC, resulting in no charges against client.

Represented medical device manufacturer in publicized criminal and civil investigations by DOJ, multiple U.S. Attorney’s Offices, FDA, and VA-OIG of allegations of non-conforming products.

Represented Fortune 50 financial institution in global settlement of municipal securities issues.

Represented Big Four audit firm in SEC investigation involving failed Puerto Rican financial institution.

Credentials

J.D., Harvard University, magna cum laude

B.A., Furman University, summa cum laude

Georgia

New York

Law Clerk, Judge Gerald Bard Tjoflat, U.S. Court of Appeals for the Eleventh Circuit